The Food and Drug Administration (FDA) has accepted for review the resubmitted Biologics License Application (BLA) for prademagene zamikeracel for the treatment of recessive dystrophic ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Abeona Therapeutics (ABEO – Research Report). The associated price ...